Discover the full record of transactions filed by Li Kei Ling, 管理人员. Officer active across 1 company, notably Dawnrays Pharmaceutical (Holdings) Ltd.. Aggregated, 11 reports have been logged. History available since 30 March 2026. The latest transaction was filed on 10 September 2026 (Purchase). Regulator: HKEX. The full history is free.
Companies and markets linked to Li Kei Ling
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Li Kei Ling is an insider and a Director of Dawnrays Pharmaceutical (Holdings) Ltd. They have 8 filings in total, and across the 8 most recent sampled filings the transactions are purchases for EUR 43012 between 2026-04-01 and 2026-06-29.